Check out the NYC Health Business 2021 Healthcare Innovation Report for thoughts from our CEO misti ushio on TARA's efforts to leverage our human-relevant datasets for cardiac drug discovery and improve efficiencies during and following the COVID lockdown in NYC: nychbl.com/wp-content/upl…

We are beyond proud of Columbia University University Professor/Columbia Medicine/Columbia BME Professor Gordana Vunjak-Novakovic Gordana Vunjak-Novakovic as she receives the Pierre Galletti Award today, AIMBE's highest honor. Congratulations, Gordana! You inspire us every single day.🌟🎉

✨ New in Nature Protocols! Milica Radisic (Milica Radisic) & Biomedical Engineering @ University of Toronto researchers describe a method to cultivate millimeter-scale functional vascularized tissues on a biofabricated platform that enables facile incorporation of #organoid technology. go.nature.com/3rIFoNA

Gordana is a finalist for the 2021 European Inventor Award, one of Europe's most prestigious innovation prizes sponsored by the EuropeanPatentOffice. Congrats Gordana Vunjak-Novakovic !! Go vote !!

Nice piece on the future of #drugdiscovery using organ-on-a-chip technology to replace #animaltesing. “Organ-on-a-chip is not just one workflow point in time,” misti ushio says. “You can use it along an entire drug discovery and development continuum.” pharmamanufacturing.com/articles/2021/…

Animal testing has never been ideal from an ethical and scientific standpoint. In this latest episode of After Animals Podcast, TARA CEO misti ushio discusses how TARA's tech could reduce pharma's reliance on #animaltesting without compromising human safety. apple.co/3rwal9k

Today we've announced an exciting #partnership with Scipher Medicine aimed to address a critical unmet need for effective therapeutics in cardiac laminopathies. Together, we’re on track to reduce target discovery and validation from years down to months. bit.ly/31nkpIF

TARA Biosystems, a biotechnology company using human biology and data for cardiac drug discovery, has collaborated with Scipher Medicine, a precision medicine company. ddw-online.com/biotech-and-pr… #Biotechnology

Interest in cardiac #DrugDiscovery and development is surging as more and more hurdles are overcome. In this whitepaper, we explore the tools and tactics fueling this new era in precision cardiac medicine. Download the whitepaper here: tarabiosystems.com/heart-failure/

Remarkable progress in three converging fields has transformed how we define, study, and treat #cardiac diseases. 1. Biomedical science 2. Tissue engineering 3. Stem cell technology Learn more in our new drug discovery whitepaper: tarabiosystems.com/heart-failure/

Learn how we engineer human heart biology and build predictive data sets that can increase the probability of success and shorten the expensive path of #cardiac drug development. #heartdisease #drugdiscovery youtube.com/watch?v=cXUnyD…

A convergence of technology breakthroughs has opened the door to precise molecular targeting and personalization. With these genetically defined subpopulations, we can develop drugs that address the true underlying cause of #cardiac diseases. Learn more: tarabiosystems.com/heart-failure/

3D cell cultures are rapidly replacing conventional tissue cultures - & even some animal test models in biology & medicine. Through the lens of #cardiacfunction modeling advancements, our CEO @MistiUshio sheds some light with Biocompare bit.ly/3DEXp5i

TARA in the The Wall Street Journal today! Newly launched VC firm, and TARA investor, OMX_Ventures aims to raise $250 Million for Latest Life-Sciences Fund and back 25 start-ups by year-end. #lifesciences #funding #startups wsj.com/articles/omx-v…

Thanks to Genetic Engineering & Biotechnology News for featuring TARA in their article "Opening new lines of attack against cardiovascular disease." We're in good company with Verve Therapeutics, Tenaya Therapeutics, BridgeBio Pharma, and Maze Therapeutics also highlighted. genengnews.com/topics/transla…

TARA's own Nicole Feric is on the ground at Society of Toxicology presenting a joint poster with @Sanofi. It highlights the sensitivity of TARA’s 3D tissues over 2D cells when predicting cardiac inotropic response in a study comparing 25 reference compounds. Stop by to learn more!

It’s official. We’re proud to announce that TARA has been acquired by Valo Health. This deal gives Valo exclusive access to our proprietary human #CardiacDisease models, which it will leverage to advance #DrugDiscovery for cardiovascular disease. prnewswire.com/news-releases/…